Retina Associates of Western New York, P.C. v. McKesson Corporation

District Court, W.D. New York·Decided September 9, 2024·No. 6:23-cv-06174·Unknown

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK

RETINA ASSOCIATES OF WESTERN NEW YORK, P.C.,

Plaintiff, Case # 23-CV-6174-FPG v. DECISION AND ORDER

McKESSON CORPORATION, et al.,

Defendants.

INTRODUCTION On November 7, 2023, the Court granted the motion to dismiss filed by Defendants McKesson Corporation (“McKesson”), McKesson Specialty Care Distribution LLC (“McKesson LLC”), and McKesson Specialty Care Distribution Corporation (“MSCDC”). ECF No. 10. Plaintiff Retina Associates of Western New York, P.C. (“RAWNY”) has filed an amended complaint, ECF No. 11, which Defendants now move to dismiss. ECF No. 14. For the reasons that follow, Defendants’ motion is GRANTED. LEGAL STANDARD A complaint will survive a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6) when it states a plausible claim for relief. Ashcroft v. Iqbal, 556 U.S. 662, 679 (2009) (citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555-56 (2007)). A claim for relief is plausible when the plaintiff pleads sufficient facts that allow the Court to draw the reasonable inference that the defendant is liable for the alleged misconduct. Iqbal, 556 U.S. at 678. In considering the plausibility of a claim, the Court must accept factual allegations as true and draw all reasonable inferences in the plaintiff’s favor. Faber v. Metro. Life Ins. Co., 648 F.3d 98, 104 (2d Cir. 2011). At the same time, the Court is not required to accord “[l]egal conclusions, deductions, or opinions couched as factual allegations . . . a presumption of truthfulness.” In re NYSE Specialists Sec. Litig., 503 F.3d 89, 95 (2d Cir. 2007) (quotation marks omitted). BACKGROUND The following facts are taken from the amended complaint, unless otherwise noted.

RAWNY is a medical practice. RAWNY asserts that, when it purchased medical products from Defendants with its credit card, Defendants failed to classify the transactions correctly, which caused RAWNY to receive reduced rebates from its credit card company. See ECF No. 11 ¶¶ 22- 30. Between April 2020 and September 2022, RAWNY lost $329,375.89 in rebates due to the alleged misclassification of its transactions. See id. ¶ 28. RAWNY contends that Defendants’ errors violated their obligations under two contractual arrangements. Id. ¶¶ 39-45. The first agreement is a “Distribution Agreement” that US Retina— a group purchasing organization—executed with MSCDC in October 2017. ECF No. 11 ¶ 12; see also ECF No. 11-2 (copy of agreement). Members of US Retina, including RAWNY, were considered to be “intended third party beneficiar[ies]” of the Distribution Agreement. ECF No.

11-2 at 3. In Section 7(H) of the Distribution Agreement, MSCDC was required to “process all credit card payments as Level 1 transactions,” ECF No. 11-2 at 10, which provide a higher rebate to RAWNY. ECF No. 11 ¶ 30. The second agreement is a “Participation Agreement” executed between McKesson LLC in October 2021. The Court detailed the terms of the Participation Agreement in its prior Decision & Order, and need not do so again here. See ECF No. 10. In its amended complaint, RAWNY brings claims against Defendants for (1) breach of the Distribution Agreement, (2) breach of the Participation Agreement, and (3) unjust enrichment, all of which are based on Defendants’ alleged misclassification of RAWNY’s credit-card purchases. ECF No. 11 at 8-9. DISCUSSION Defendants move to dismiss the amended complaint in its entirety. The Court examines

the claims against each defendant in turn. I. Claims against MSCDC RAWNY concedes that, in November 2018, MSCDC “converted to McKesson LLC,” and they are now “one and [the] same entity.” ECF No. 11 ¶ 5. Defendants contend that MSCDC is no longer a proper party because, as a dissolved entity, MSCDC lacks the capacity to sue or be sued under Delaware law. See ECF No. 14-1 at 18-19. RAWNY fails to respond to this specific contention. See ECF No. 19 at 11-13. As a result, RAWNY is deemed to have “effectively conceded the argument.” Ventillo v. Falco, No. 19-CV-3664, 2020 WL 7496294, at *12 (S.D.N.Y. Dec. 18, 2020) (internal quotation marks, brackets, and ellipsis omitted); see also Felske v. Hirschmann, No. 10-CV-8899, 2012 WL 716632, at *3 (S.D.N.Y. Mar. 1, 2012) (“A plaintiff

effectively concedes a defendant’s arguments by his failure to respond to them.”). For this reason, the Court grants Defendants’ motion and dismisses the claims against MSCDC with prejudice. II. Claims against McKesson McKesson is not a signatory to either of the relevant agreements. In general, under New York law, “a breach of contract claim cannot be asserted against a non-signatory to the contract, unless a plaintiff pleads liability on veil piercing or alter ego theories.” Buffalo Xerographix, Inc. v. Hartford Ins. Grp., 540 F. Supp. 3d 382, 391 (W.D.N.Y. 2021) (internal quotation marks and alterations omitted). In its prior Decision & Order, the Court concluded that RAWNY “failed to sufficiently allege facts [to] . . . plausibly support an agency theory for its breach of contract claim against McKesson.” ECF No. 10 at 14. The Court expressly rejected RAWNY’s position that “three facts [] support the existence of an agency relationship: (1) a McKesson employee accepted RAWNY’s electronically signed Participation Agreement and other McKesson employees received copies of the signed agreement, (2) RAWNY’s contacts under the Participation

Agreement were McKesson employees using McKesson email accounts; and (3) RAWNY was required to purchase drugs directly from McKesson under the Distribution Agreement.” Id. Defendants move to dismiss the claims against McKesson, arguing that the amended complaint fails to cure this defect. Although RAWNY asserts that “McKesson dominated” McKesson LLC and MSCDC, ECF No. 19 at 17, the amended complaint provides no allegations to support that legal conclusion. See generally ECF No. 11. Accordingly, for the reasons stated in the prior Decision & Order, the breach-of-contract claim against McKesson must be dismissed. See ECF No. 10 at 13-15. In addition, because RAWNY fails to plausibly allege an agency relationship between McKesson and McKesson LLC, it cannot maintain an unjust-enrichment claim against McKesson on the basis of McKesson LLC’s alleged actions. See In re CIL Ltd., 582

B.R. 46, 123 (S.D.N.Y. 2018). Therefore, the claims against McKesson are dismissed with prejudice. III. Claims against McKesson LLC In its amended complaint, RAWNY asserts that McKesson LLC breached the Distribution Agreement and the Participation Agreement when it failed to process RAWNY’s credit-card transactions as Level 1 purchases. See ECF No. 11 at 8. It also alleges that McKesson LLC was unjustly enriched as a result. See id. at 9. The Court begins with the contract claims. Under New York law, to “recover from a defendant for breach of contract, a plaintiff must prove, by a preponderance of the evidence, (1) the existence of a contract between itself and that defendant; (2) performance of the plaintiff’s obligations under the contract; (3) breach of the contract by that defendant; and (4) damages to the plaintiff caused by that defendant’s breach.” Diesel Props. S.r.l. v. Greystone Bus. Credit II LLC, 631 F.3d 42, 52 (2d Cir. 2011).

Free access — add to your briefcase to read the full text and ask questions with AI

Retina Associates of Western New York, P.C. v. McKesson Corporation, (W.D.N.Y. 2024).

Retina Associates of Western New York, P.C. v. McKesson Corporation (Retina Associates of Western New York, P.C. v. McKesson Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re NYSE Specialists Securities Litigation
503 F.3d 89 (Second Circuit, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Faber v. Metropolitan Life Insurance
648 F.3d 98 (Second Circuit, 2011)
Williams v. Citigroup Inc.
659 F.3d 208 (Second Circuit, 2011)